Compounds > quinuclidines

Page last updated: 2024-08-18

quinuclidines and Syndrome

quinuclidines has been researched along with Syndrome in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (9.09)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (54.55)	29.6817
2010's	4 (36.36)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aguado-Jodar, A; Ibáñez-Nolla, J; Kvasz, M; Navarro-Artieda, R; Rejas, J; Ruiz-Torrejón, A; Sicras-Mainar, A	1
Grinta, R; Vecchioli-Scaldazza, C	1
Kuo, HC; Lin, H; Liu, HT	1
Brubaker, L; Durazo-Arivzu, RA; Fitzgerald, MP; Kenton, K; Lowenstein, L; Mueller, ER; Sabo, E	1
Cardozo, L; Robinson, D	1
Jonas, U; Rackley, RR	1
Simpson, D; Wagstaff, AJ	1
Serels, S	1
Hashim, H	1
Sieber, P; Wagg, A; Wyndaele, JJ	1
Bajgar, J; Fusek, J; Herink, J; Hrdina, V; Koupilová, M; Patocka, J	1

Reviews

3 review(s) available for quinuclidines and Syndrome

Article	Year
Solifenacin in the management of the overactive bladder syndrome. International journal of clinical practice, 2005, Volume: 59, Issue:10 Topics: Clinical Trials as Topic; Humans; Quinuclidines; Receptor, Muscarinic M3; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Urinary Bladder Diseases; Urinary Incontinence; Urination Disorders	2005
Solifenacin in overactive bladder syndrome. Drugs & aging, 2005, Volume: 22, Issue:12 Topics: Humans; Muscarinic Antagonists; Quality of Life; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Urinary Incontinence	2005
Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis. The American journal of geriatric pharmacotherapy, 2006, Volume: 4, Issue:1 Topics: Aged; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Female; Humans; Male; Muscarinic Antagonists; Quinuclidines; Randomized Controlled Trials as Topic; Retrospective Studies; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Urinary Incontinence	2006

Other Studies

8 other study(ies) available for quinuclidines and Syndrome

Article	Year
Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain. BMC urology, 2013, Oct-21, Volume: 13 Topics: Aged; Benzhydryl Compounds; Cholinergic Agents; Cost-Benefit Analysis; Cresols; Female; Health Care Costs; Humans; Male; Phenylpropanolamine; Prevalence; Primary Health Care; Quinuclidines; Retrospective Studies; Solifenacin Succinate; Spain; Syndrome; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents	2013
Overactive bladder syndrome: what is the role of evidence of detrusor overactivity in the cystometric study? Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2010, Volume: 62, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Cystostomy; Female; Humans; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quinuclidines; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Stress; Urodynamics	2010
Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy. Neurourology and urodynamics, 2011, Volume: 30, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Creatinine; Drug Resistance; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Nerve Growth Factor; Quinuclidines; Solifenacin Succinate; Syndrome; Taiwan; Tetrahydroisoquinolines; Time Factors; Treatment Failure; Up-Regulation; Urinary Bladder; Urinary Bladder, Overactive; Young Adult	2011
Solifenacin objectively decreases urinary sensation in women with overactive bladder syndrome. International urology and nephrology, 2012, Volume: 44, Issue:2 Topics: Aged; Diagnostic Techniques, Urological; Equipment Design; Female; Follow-Up Studies; Humans; Middle Aged; Muscarinic Antagonists; Predictive Value of Tests; Quinuclidines; Reproducibility of Results; Sensation; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urodynamics	2012
Re: Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T, Wright DM, Bolodeoku J. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome European urology, 2006, Volume: 49, Issue:1 Topics: Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence	2006
Solifenacin in overactive bladder syndrome: a viewpoint by Scott Serels. Drugs & aging, 2005, Volume: 22, Issue:12 Topics: Humans; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Urinary Incontinence	2005
Solifenacin in overactive bladder: a viewpoint by Hashim Hashim. Drugs & aging, 2005, Volume: 22, Issue:12 Topics: Animals; Humans; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Urinary Incontinence	2005
The interaction of anticholinesterases and diazepam in the treatment of anticholinergic syndrome in dogs. Activitas nervosa superior, 1979, Volume: 21, Issue:3 Topics: Acridines; Animals; Diazepam; Dogs; Drug Combinations; Quinuclidines; Quinuclidinyl Benzilate; Syndrome; Tacrine	1979